“…In the first step, the cells were treated at T0, checked every 24 h, and maintained for 144 h (protocol A); in the second step, the cells were treated every 24 h, checked every 24 h, and maintained for 144 h (protocol B). We also tested in protocol A the involvement of muscarinic receptors and calcium using a specific antagonist, treating cells 30 min before stimulation; in particular, for muscarinic receptor 1 we used atropine (7.25 μg/mL; Sigma, Milan, Italy) [Kühne et al, 2015] and for calcium we used H89 (519 ng/mL, inhibitor of PKA kinase; Sigma) and chelerythrine (384 ng/mL, inhibitor of PKC kinase; Cayman Chemicals, Cabru, Milan, Italy) [Chernyavsky et al, 2009;Cappellano et al, 2013].…”